VANECK ETF TR (BBH) - 5i Research

VANECK ETF TR (BBH $189.26)
- $189.26 P/E (TTM): 21.6X Cap: $375M
- View BBH Profile
- View Questions on BBH

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

iShares Biotechnology ETF (IBB $168.77)
- $168.77 P/E (TTM): 21.3X Cap: $8.46B
- View IBB Profile
- View Questions on IBB
Moderna Inc. (MRNA $29.49)
- $29.49 Cap: $11.52B
- View MRNA Profile
- View Questions on MRNA
VANECK ETF TR (BBH $189.26)
- $189.26 P/E (TTM): 21.6X Cap: $375M
- View BBH Profile
- View Questions on BBH

Q: Currently not invested in this sector. Considering starting a position in this company. Appreciate your insights.
Thank you

Read Answer Asked by Larry on September 07, 2023

iShares Biotechnology ETF (IBB $168.77)
- $168.77 P/E (TTM): 21.3X Cap: $8.46B
- View IBB Profile
- View Questions on IBB
CRISPR Therapeutics AG (CRSP $52.44)
- $52.44 Cap: $4.99B
- View CRSP Profile
- View Questions on CRSP
VANECK ETF TR (BBH $189.26)
- $189.26 P/E (TTM): 21.6X Cap: $375M
- View BBH Profile
- View Questions on BBH

Q: I am down by 55% on this company, although it is a small position (.8%) & I consider it speculative. Your comments will help me decide to wait, sell, or buy more. Thanks

Read Answer Asked by Louisa on March 30, 2023

Regeneron Pharmaceuticals Inc. (REGN $771.87)
- $771.87 P/E (TTM): 15.61X Cap: $81.12B
- View REGN Profile
- View Questions on REGN
Johnson & Johnson (JNJ $206.95)
- $206.95 P/E (TTM): 18.01X Cap: $498.60B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $1,074.68)
- $1,074.68 P/E (TTM): 41.32X Cap: $1.01T
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $105.26)
- $105.26 P/E (TTM): 11.28X Cap: $261.25B
- View MRK Profile
- View Questions on MRK
Pfizer Inc. (PFE $24.90)
- $24.90 P/E (TTM): 14.33X Cap: $141.57B
- View PFE Profile
- View Questions on PFE
Thermo Fisher Scientific Inc (TMO $579.45)
- $579.45 P/E (TTM): 31.97X Cap: $217.70B
- View TMO Profile
- View Questions on TMO
Novo Nordisk A/S (NVO $50.88)
- $50.88 P/E (TTM): 27.17X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
iShares Biotechnology ETF (IBB $168.77)
- $168.77 P/E (TTM): 21.3X Cap: $8.46B
- View IBB Profile
- View Questions on IBB
Moderna Inc. (MRNA $29.49)
- $29.49 Cap: $11.52B
- View MRNA Profile
- View Questions on MRNA
VANECK ETF TR (BBH $189.26)
- $189.26 P/E (TTM): 21.6X Cap: $375M
- View BBH Profile
- View Questions on BBH
iShares U.S. Pharmaceuticals ETF (IHE $84.83)
- $84.83 P/E (TTM): 22.53X Cap: $852M
- View IHE Profile
- View Questions on IHE

Q: I'm looking for names in the large cap pharma and biotech sectors. Can you suggest two stocks for each sector that look attractive to you right now for a 5+ year horizon? Thanks.

Read Answer Asked by Stefan on March 10, 2023